Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

August 17, 2015November 9, 2015

Study Finds That Patients with COPD and Comorbid Psychological Conditions are at Increased Risk For Hospital Readmission

COPD, News

In a study recently published in the journal CHEST, a team of researchers from The University of Texas Medical Branch at Galveston determined that people with a psychological disorder such as ... Read more

August 13, 2015November 6, 2015

Review Explores Role of Psychological Aspects in Asthma Control

Asthma, News

In a recent review published in the journal Asthma Research and Practice, a team of researchers explored the role of psychological factors associated to the unsuccessful fulfillment of optimal levels ... Read more

August 13, 2015November 5, 2015

Study Shows Lynovex Outperforms Ciprofloxacin and Tobramycin in Killing Cystic Fibrosis Sputum Mycobacterium Abscessus

Cystic Fibrosis, News

Results from a recent study published in the journal EBioMedicine revealed positive activity of NovaBiotics’ investigational cystic fibrosis (CF) drug candidate Lynovex. The study, conducted in collaboration between NovaBiotics, a clinical-stage ... Read more

August 12, 2015August 12, 2015

Diplomat Pharmacy To Offer IRESSA as First-line Treatment for Non-small Cell Lung Cancer

Lung Cancer, News

Diplomat Pharmacy, Inc., a company focused on medication management programs for people with complex chronic diseases, recently announced that IRESSA® (gefitinib), a recently approved drug by the U.S. Food and ... Read more

August 11, 2015November 6, 2015

Study Shows That First-Trimester Exposure to Asthma Beta-2 Agonist Drugs Increases Birth Defect Risk

Asthma, News

Results from a recent study published in the Journal of Allergy and Clinical Immunology showed that exposure to inhaled beta-2 agonists during the first trimester of pregnancy appeared to increase ... Read more

August 7, 2015November 5, 2015

Review Reveals Epigenetics as a Potential Therapeutic Strategy for Pulmonary Arterial Hypertension

News, Pulmonary Hypertension

In a recent review published in the journal Experimental & Molecular Medicine, a team of researchers provided a general overview of the current advances in epigenetics associated with Pulmonary arterial ... Read more

August 6, 2015November 5, 2015

Results from Meta-analysis Show That Exercise Training is Safe & Effective for Patients with Pulmonary Hypertension

News, Pulmonary Hypertension

In a recent meta-analysis published in the journal Circulation: Heart Failure, the journal of the American Heart Association, a team of researchers found that exercise training is effective and safe ... Read more

August 6, 2015November 5, 2015

Study Finds That Connectivity of Cystic Fibrosis Centers Increases Risk for Acquisition of Shared P Aeruginosa Strain Infections

Cystic Fibrosis, News

Results from a recent study published in the Lancet Respiratory Medicine show that the connectivity of cystic fibrosis centers, as measured by the movement of patients between them, seems to ... Read more

July 31, 2015November 6, 2015

Study Determines That SSc May Not Be a Progressive Disease in All Cases

News, Scleroderma

In a study recently presented during the European League Against Rheumatism Annual European Congress of Rheumatology (EULAR 2015), a team of researchers found that fatigue and functional limitations remained stable ... Read more

July 30, 2015November 5, 2015

Moerae Initiates Second Phase 1 study of MMI-0100 for Lung Diseases

Idiopathic Pulmonary Fibrosis, News

Moerae Matrix Inc., a privately held biopharmaceutical company focused on the development of first-in-class targeted therapeutics for fibrotic diseases, recently announced the initiation of its second Phase 1 clinical trial ... Read more